United States · FDA National Drug Code directory
Cyclobenzaprine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63629-8206_9883a891-91a6-4b0c-827d-59bc6b14b0ae
- Product NDC
- 63629-8206
- Form
- CAPSULE, EXTENDED RELEASE
- Composition / generic term
- Cyclobenzaprine Hydrochloride
- Labeler
- Bryant Ranch Prepack
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start / end (source format)
- 20190304
- Source listing expiry
- 20261231
Source-listed ingredients
- CYCLOBENZAPRINE HYDROCHLORIDE — 15 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (63629-8206-1) · 63629-8206-1
- 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (63629-8206-2) · 63629-8206-2
- 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (63629-8206-3) · 63629-8206-3
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →